Grail (GRAL) Cash from Operations (2023 - 2026)
Grail's (GRAL) quarterly Cash from Operations came in at -$80.7 million in Q2 2026, down 4.89% on a YoY basis from -$84.9 million in Q2 2025, and up 7.2% quarter-over-quarter from -$87.0 million in Q1 2026.
Analysis
Grail (GRAL) Cash from Operations (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Cash from Operations for 4 consecutive years, with -$80.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Operations fell 4.89% year-over-year to -$80.7 million; the trailing twelve-month figure through Jun 2026 stood at -$294.7 million (up 20.35% YoY), and the FY2025 full-year result was -$299.0 million, up 48.19% from the prior year.
- Cash from Operations grew to -$80.7 million in Q2 2026 per GRAL's latest filing, from -$87.0 million in the prior quarter.
- Across five years, Cash from Operations topped out at -$63.2 million in Q3 2025 and bottomed at -$207.3 million in Q1 2024.
- Historically, Cash from Operations has averaged -$110.9 million across 4 years, with a median of -$94.3 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Cash from Operations soared 55.2% in 2025, then decreased 4.89% in 2026.
- Over 4 years, Cash from Operations stood at -$128.9 million in 2023, then advanced by 27.47% to -$93.5 million in 2024, then soared by 31.77% to -$63.8 million in 2025, then fell by 26.57% to -$80.7 million in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered -$80.7 million, -$87.0 million, and -$63.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 54.79 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 597.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 445.50 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -57.78 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | -7.53 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 28.48 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 88.50 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 9.14 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -6.40 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | -80.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -80.73 Mn |
| Mar 31, 2026 | -86.99 Mn |
| Dec 31, 2025 | -63.79 Mn |
| Sep 30, 2025 | -63.25 Mn |
| Jun 30, 2025 | -76.97 Mn |
| Mar 31, 2025 | -95.01 Mn |
| Dec 31, 2024 | -93.49 Mn |
| Sep 30, 2024 | -104.58 Mn |
| Jun 30, 2024 | -171.80 Mn |
| Mar 31, 2024 | -207.29 Mn |
| Dec 31, 2023 | -128.90 Mn |
| Oct 1, 2023 | -157.51 Mn |